Senores Pharmaceuticals Limited (NSE:SENORES)
India flag India · Delayed Price · Currency is INR
514.85
-0.25 (-0.05%)
Last updated: May 22, 2025

Senores Pharmaceuticals Revenue

In the fiscal year ending March 31, 2025, Senores Pharmaceuticals had annual revenue of 4.18B INR with 94.62% growth. Senores Pharmaceuticals had revenue of 1.26B in the quarter ending March 31, 2025, with 20.67% growth.

Revenue
4.18B
Revenue Growth
+94.62%
P/S Ratio
5.66
Revenue / Employee
28.79M
Employees
113
Market Cap
23.61B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 20254.18B2.03B94.62%
Mar 31, 20242.15B1.79B507.08%
Mar 31, 2023353.37M211.67M149.38%
Mar 31, 2022141.70M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition